25th Conference on Intelligent Systems for Molecular Biology (ISMB) and 16th European Conference on Computational Biology (ISMB/ECCB 2017) Jul 21, 2017 20170721 Jul 25, 2017 Prague Congress Centre: 5. května 1640/65 Praha 4 - Nusle-Praha 4 Czech Republic ISMB/ECCB 2017 provides an intense multidisciplinary forum for disseminating the latest developments in bioinformatics/computational biology, fostering fresh dialogues and perspectives to learn about and shape the future of the field. In response to the increasing interest in the activities of the ISCB’s Communities of Special Interest (COSIs) who have previously organized the Special Interest Group (SIG) meetings at ISMB, ISMB/ECCB 2017 will be organized with the active participation of the COSIs. ISMB/ECCB 2017 will be more streamlined and will have an outstanding scientifically effective program. /content/dam/pmiscience/default-fallback-thumbnails/conference/phillip-morris-science1-detail.png

      25th Conference on Intelligent Systems for Molecular Biology (ISMB) and 16th European Conference on Computational Biology (ISMB/ECCB 2017)

      Date
      Jul 21, 2017 - Jul 25, 2017
      Location
      Prague Congress Centre: 5. května 1640/65 Praha 4 - Nusle-Praha 4 Czech Republic
      ISMB/ECCB 2017 provides an intense multidisciplinary forum for disseminating the latest developments in bioinformatics/computational biology, fostering fresh dialogues and perspectives to learn about and shape the future of the field. In response to the increasing interest in the activities of the ISCB’s Communities of Special Interest (COSIs) who have previously organized the Special Interest Group (SIG) meetings at ISMB, ISMB/ECCB 2017 will be organized with the active participation of the COSIs. ISMB/ECCB 2017 will be more streamlined and will have an outstanding scientifically effective program.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.